Cutera
Cutera is a Nasdaq-listed medical aesthetics company that designs FDA-cleared laser, radiofrequency, and IPL devices for dermatologists, plastic surgeons, and medical spas, with a portfolio spanning acne treatment, body sculpting, skin revitalization, and tattoo removal.
- Company typePublic
- Founded1998
- HeadquartersBrisbane, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Cutera does
Cutera is a Nasdaq-listed medical aesthetics company (ticker: CUTR), founded in 1998 and headquartered in Brisbane, California, that designs and manufactures energy-based aesthetic devices for dermatologists, plastic surgeons, and medical spas. The company's portfolio spans laser platforms (Nd:YAG, CO2, 1726nm), radiofrequency (RF) systems including monopolar and microneedling, and intense pulsed light (IPL) systems. Flagship products include AviClear (the first FDA-cleared energy device for long-term acne treatment at 1726nm), the truSculpt/truFlex/truBody body-sculpting franchise (with clinically demonstrated ~24% average fat reduction), the Secret RF/PRO/DUO resurfacing line, excel V/V+ for vascular and pigmentary conditions, xeo and xeo+ multi-application platforms, enlighten for tattoo and pigment removal, and excel HR for hair removal. The company holds multiple registered trademarks (AviClear, truSculpt, truFlex, Secret, excel, enlighten, xeo, truBody, Laser Genesis, PICO Genesis) that anchor its brand across dermatology and consumer-facing publications.
Cutera generates revenue through three streams: capital equipment sales at $120,000–$300,000 per platform, recurring consumables (handpieces and tips), and service contracts (which grew 7% in Q2 2024). Distribution is primarily direct enterprise field sales targeting aesthetic physicians and dermatology practices, supplemented by wholly-owned regional subsidiaries across the US, Australia, Belgium, France, Germany, Japan, Switzerland, and the UK. A strategic channel partnership with L'Oréal Japan Co. extends reach into the Japanese medical aesthetics market via exclusive distribution of SkinCeuticals products. Marketing emphasizes clinical evidence, FDA clearances, and provider education through Cutera Academy webinars, trade shows, and a Provider Finder tool that drives patient demand to equipped practitioners.
The company has encountered material headwinds. Q2 2024 consolidated revenue of $34.4M missed expectations, especially in North America, despite 41% international AviClear growth and 7% service revenue growth. The company has executed leadership changes and ongoing restructuring and cost-reduction measures, and filed for Chapter 11 bankruptcy protection in March 2025 amid industry-wide pressure from inflation, supply-chain disruption, and shifting consumer spending. Despite this, Cutera continues to operate globally and pursue product-line expansion, including FDA-cleared expansion of truFlex into rehabilitative and therapeutic indications.
Cutera firmographics
Firmographics- Name
- Cutera
- Legal name
- Cutera, Inc.
- Website
- https://cutera.com
- Company type
- Public
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Cutera is a Nasdaq-listed medical aesthetics company that designs FDA-cleared laser, radiofrequency, and IPL devices for dermatologists, plastic surgeons, and medical spas, with a portfolio spanning acne treatment, body sculpting, skin revitalization, and tattoo removal.
- Ownership category
- akta.pro rank
Cutera industry classification
Industry- Product category
- Medical Aesthetic Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Professional Skincare & Facial Treatments (CRABALAF)
Keywords
Where Cutera is headquartered
LocationHeadquarters
- HQ city
- Brisbane
- HQ country
- United States
- HQ region
- North America
Offices8 records
Markets served
Cutera business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Capital Equipment Sales: Sale of laser and radiofrequency aesthetic devices to dermatology clinics and medical spas. Equipment includes xeo+ platform, AviClear, truSculpt, truFlex, Secret RF, excel V+, and enlighten systems. Revenue recognition occurs upon device delivery with typical capital expenditure ranging from $120,000 to $300,000 per unit.
- Consumables: Recurring revenue from consumables used with Cutera devices during patient treatments. This includes handpieces, tips, and other disposable components that require replacement over the device lifecycle.
- Service Contracts: Recurring service and maintenance revenue from service contracts offered to device owners. The company reported 7% growth in service revenue, providing predictable recurring income stream.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Capital equipment pricing varies by platform configuration and product bundle |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
Cutera product offering
Product offeringCore offering
Cutera designs, manufactures, and sells energy-based medical aesthetic devices—including laser platforms (Nd:YAG, CO2, picosecond), radiofrequency systems, and intense pulsed light (IPL) systems—for dermatology clinics, plastic surgery practices, and medical spas. Its portfolio addresses acne treatment, body sculpting, skin revitalization, hair removal, tattoo removal, and vascular/pigmentary lesions. Revenue comes primarily from capital equipment sales ($120,000–$300,000 per unit), with recurring income from consumables and service contracts.
Product overview
Cutera is a medical aesthetics company offering a portfolio of energy-based devices for dermatology and aesthetic clinics. The product portfolio includes laser and RF platforms for acne treatment (AviClear), body sculpting (truSculpt, truFlex, truBody platform), skin revitalization and resurfacing (Secret RF, Secret PRO, Secret DUO, excel V, excel V+), hair removal (excel HR, xeo+), tattoo removal (enlighten), and pigmented/vascular lesion treatment (xeo+, xeo). The devices range from single-application systems to multi-platform solutions like xeo+ that combine Nd:YAG laser with IPL technology. Products are designed for use in dermatology clinics and medical spas, with recurring revenue from consumables and service contracts.
Differentiator
Problem solved
Functional benefit
Brands
- truBody: Body sculpting solution combining truSculpt and truFlex technologies for fat reduction and muscle building.
- AviClear
- Secret
- excel
- xeo
- truSculpt
- truFlex
- enlighten
- excel HR
Products and services
- AviClear The first and original FDA-cleared energy device for the long-term treatment of all acne severities, using 1726nm laser technology. Designed for dermatologists and aesthetic physicians offering non-invasive acne treatment.
- xeo+ Multi-application laser and IPL platform for skin revitalization, vascular lesions, pigment reduction, hair removal, and wrinkle treatment, featuring Nd:YAG laser and tunable IPL handpieces. Targeted at dermatology and aesthetic practices seeking a single device for multiple treatment categories.
- truSculpt Non-invasive monopolar RF body sculpting platform delivering an average of 24% fat reduction in a single 15-minute hands-free treatment. Designed for aesthetic practices offering non-invasive body contouring.
- truFlex Rapid muscle sculpting technology using electrical muscle stimulation, now FDA-cleared for both aesthetic and rehabilitative/therapeutic applications. Targets body contouring and muscle development for aesthetic practices and rehabilitation providers.
- excel V+ Precision laser system designed with input from leading dermatologists for treating vascular and pigmentation conditions with power, precision, and performance. For dermatology and aesthetic practices.
- Secret PRO Combines RF microneedling with CO2 laser for skin resurfacing, designed to treat all skin layers with optimal results and minimal downtime. For aesthetic and dermatology practices.
- Secret RF RF microneedling system using gold-plated micro-needles to deliver fractional radiofrequency energy beneath the skin surface for revitalization and regeneration across all skin types. For dermatology practices.
- Secret DUO Combines RF microneedling with 1540nm and CO2 laser options for dynamic facial resurfacing and remodeling. For aesthetic practices seeking combined modality treatments.
- enlighten Versatile picosecond and nanosecond laser technology for multi-color tattoo removal, benign pigmented lesion treatment, and skin revitalization including PICO Genesis treatments. For dermatology and aesthetic practices.
- excel HR Laser system for hair removal, pigmented lesions, and vascular lesions. For dermatology and medical spa practices.
- excel V Laser system for skin revitalization, pigmented lesions, and vascular lesions. For dermatology practices.
- xeo Multi-application aesthetic platform for veins, pigment, wrinkles, hair removal, and skin revitalization. For aesthetic practices seeking consolidated device solutions.
- truBody Body sculpting solution combining truSculpt (fat reduction) and truFlex (muscle building) technologies for personalized body contouring results. A treatment platform offered to practices rather than a single device.
Quantifiable outcome
- 24% average fat reduction in single truSculpt treatment session
- +3 more outcomes
Companies that use Cutera
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles1 record
Cutera technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Cutera partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- L'Oréal Japan Co.coreStrategic partnership for exclusive distribution of SkinCeuticals products to medical clinics in Japan. Cutera leverages this partnership to expand its presence in the Japanese medical aesthetics market by combining its device offerings with skincare product distribution through established retail channels.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Cutera competitors and assessment
Company assessmentDirect peers
- Cynosure: Cynosure (owned by Hologic) is one of Cutera's closest direct competitors, offering a broad portfolio of energy-based aesthetic devices including laser and RF platforms for hair removal, skin revitalization, body contouring, and vascular treatments sold to dermatology clinics and medspas.
- Lumenis: Lumenis (now part of Boston Scientific) pioneered several energy-based aesthetic and surgical technologies and competes directly with Cutera in laser and IPL-based aesthetic treatments for dermatology and aesthetic practices.
- InMode: InMode develops RF-based aesthetic devices (BodyTite, Morpheus8, Evolve) that compete with Cutera's truSculpt, Secret RF, and truFlex in body contouring, microneedling, and muscle stimulation categories.
- Alma Lasers: Alma Lasers is a leading global developer of laser, RF, IPL, and ultrasound-based aesthetic and medical devices. It directly competes with Cutera across hair removal, body contouring, skin rejuvenation, and women's health indications, serving dermatologists, plastic surgeons, and medspas worldwide.
- Syneron Candela: Syneron Candela offers laser and IPL platforms (e.g., Gentle series, PicoWay, CO2RE) that compete directly with Cutera's excel, enlighten, and xeo+ systems across hair removal, pigmentation, tattoo removal, and skin revitalization indications.
- Venus Concept: Venus Concept markets energy-based devices for body contouring, hair removal, skin tightening, and facial rejuvenation, competing with Cutera across multiple product categories and serving similar dermatology and medspa customers.
- Solta Medical: Solta Medical (a Bausch Health company) markets Thermage, Fraxel, Clear+Brilliant, and Liposonix devices that overlap directly with Cutera's truSculpt (RF body contouring), Secret RF (microneedling), and enlighten (resurfacing) franchises.
- Sciton: Sciton manufactures premium laser and light-based aesthetic platforms for skin resurfacing, vascular lesions, and body contouring. It targets the same high-end dermatology and plastic surgery practices as Cutera, with overlapping indications.
Broad incumbents
- Allergan Aesthetics (AbbVie): Allergan Aesthetics, an AbbVie company, is a broad incumbent in medical aesthetics (Botox, CoolSculpting, SkinMedica) that competes with Cutera across practice economics and patient mindshare, even though its primary technology (injectables, cryolipolysis) differs from Cutera's energy-based devices.
Emerging players
- BTL Industries: BTL Industries is a fast-growing developer of non-invasive aesthetic devices (Emsculpt for muscle building, Emface, Exilis) that overlap with Cutera's truFlex and truSculpt franchises and have been taking share in body sculpting and facial aesthetics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Cutera social profiles
Digital presenceCutera financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cutera leadership team
Management profileNumber of profiles
Profiles10 records
Cutera subsidiaries and ownership
Company hierarchySubsidiaries7 records
Cutera funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cutera M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cutera
What does Cutera do?
Cutera designs, manufactures, and sells energy-based medical aesthetic devices—including laser platforms (Nd:YAG, CO2, picosecond), radiofrequency systems, and intense pulsed light (IPL) systems—for dermatology clinics, plastic surgery practices, and medical spas. Its portfolio addresses acne treatment, body sculpting, skin revitalization, hair removal, tattoo removal, and vascular/pigmentary lesions. Revenue comes primarily from capital equipment sales ($120,000–$300,000 per unit), with recurring income from consumables and service contracts.
Is Cutera a public or private company?
Cutera is a public company. It is classified as public and is currently operating.
When was Cutera founded?
Cutera was founded in 1998. It employs 251 to 500 people.
Where is Cutera based?
Cutera is headquartered in Brisbane, United States, in the North America region.
How does Cutera make money?
Three revenue lines are on record. Capital Equipment Sales are the primary driver. The others are consumables and service Contracts.
Who are Cutera's main competitors?
Direct peers on record are Cynosure, Lumenis, InMode, Alma Lasers, Syneron Candela, Venus Concept, Solta Medical and Sciton. Allergan Aesthetics (AbbVie) is listed as a broad incumbent. BTL Industries is listed as an emerging player.
Does Cutera have an API?
No public API is recorded for Cutera.
What industry is Cutera in?
Cutera's product category is Medical Aesthetic Devices. Its primary akta.pro industry code is CRABALAF, Professional Skincare & Facial Treatments. Its NAICS code is 339112 and its SIC code is 3841.